Skip to main content
NCBI home page
Archives of Disease in Childhood logoLink to Archives of Disease in Childhood
. 1990 Oct;65(10 Spec No):1076–1081. doi: 10.1136/adc.65.10_spec_no.1076

Bronchopulmonary dysplasia: then and now.

W H Northway Jr 1
PMCID: PMC1590254  PMID: 2241231

Full text

PDF
1076

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abman S. H., Burchell M. F., Schaffer M. S., Rosenberg A. A. Late sudden unexpected deaths in hospitalized infants with bronchopulmonary dysplasia. Am J Dis Child. 1989 Jul;143(7):815–819. doi: 10.1001/archpedi.1989.02150190065022. [DOI] [PubMed] [Google Scholar]
  2. Abman S. H., Warady B. A., Lum G. M., Koops B. L. Systemic hypertension in infants with bronchopulmonary dysplasia. J Pediatr. 1984 Jun;104(6):928–931. doi: 10.1016/s0022-3476(84)80501-6. [DOI] [PubMed] [Google Scholar]
  3. Anderson W. R., Engel R. R. Cardiopulmonary sequelae of reparative stages of bronchopulmonary dysplasia. Arch Pathol Lab Med. 1983 Nov;107(11):603–608. [PubMed] [Google Scholar]
  4. Bader D., Ramos A. D., Lew C. D., Platzker A. C., Stabile M. W., Keens T. G. Childhood sequelae of infant lung disease: exercise and pulmonary function abnormalities after bronchopulmonary dysplasia. J Pediatr. 1987 May;110(5):693–699. doi: 10.1016/s0022-3476(87)80004-5. [DOI] [PubMed] [Google Scholar]
  5. Berman W., Jr, Yabek S. M., Dillon T., Burstein R., Corlew S. Evaluation of infants with bronchopulmonary dysplasia using cardiac catheterization. Pediatrics. 1982 Nov;70(5):708–712. [PubMed] [Google Scholar]
  6. Bonikos D. S., Bensch K. G., NORTHWAY W. H., Jr, Edwards D. K. Bronchopulmonary dysplasia: the pulmonary pathologic sequel of necrotizing bronchiolitis and pulmonary fibrosis. Hum Pathol. 1976 Nov;7(6):643–666. doi: 10.1016/s0046-8177(76)80077-9. [DOI] [PubMed] [Google Scholar]
  7. Bonikos D. S., Bensch K. G., Northway W. H., Jr Oxygen toxicity in the newborn. The effect of chronic continuous 100 percent oxygen exposure on the lungs of newborn mice. Am J Pathol. 1976 Dec;85(3):623–650. [PMC free article] [PubMed] [Google Scholar]
  8. Bryan M. H., Hardie M. J., Reilly B. J., Swyer P. R. Pulmonary function studies during the first year of life in infants recovering from the respiratory distress syndrome. Pediatrics. 1973 Aug;52(2):169–178. [PubMed] [Google Scholar]
  9. Campbell E. J., Wald M. S. Hypoxic injury to human alveolar macrophages accelerates release of previously bound neutrophil elastase. Implications for lung connective tissue injury including pulmonary emphysema. Am Rev Respir Dis. 1983 May;127(5):631–635. doi: 10.1164/arrd.1983.127.5.631. [DOI] [PubMed] [Google Scholar]
  10. Coalson J. J., Kuehl T. J., Escobedo M. B., Hilliard J. L., Smith F., Meredith K., Null D. M., Jr, Walsh W., Johnson D., Robotham J. L. A baboon model of bronchopulmonary dysplasia. II. Pathologic features. Exp Mol Pathol. 1982 Dec;37(3):335–350. doi: 10.1016/0014-4800(82)90046-6. [DOI] [PubMed] [Google Scholar]
  11. Cummings J. J., D'Eugenio D. B., Gross S. J. A controlled trial of dexamethasone in preterm infants at high risk for bronchopulmonary dysplasia. N Engl J Med. 1989 Jun 8;320(23):1505–1510. doi: 10.1056/NEJM198906083202301. [DOI] [PubMed] [Google Scholar]
  12. Dunn M. S., Shennan A. T., Hoskins E. M., Lennox K., Enhorning G. Two-year follow-up of infants enrolled in a randomized trial of surfactant replacement therapy for prevention of neonatal respiratory distress syndrome. Pediatrics. 1988 Oct;82(4):543–547. [PubMed] [Google Scholar]
  13. Edwards D. K., Dyer W. M., Northway W. H., Jr Twelve years' experience with bronchopulmonary dysplasia. Pediatrics. 1977 Jun;59(6):839–846. [PubMed] [Google Scholar]
  14. Enhorning G., Shennan A., Possmayer F., Dunn M., Chen C. P., Milligan J. Prevention of neonatal respiratory distress syndrome by tracheal instillation of surfactant: a randomized clinical trial. Pediatrics. 1985 Aug;76(2):145–153. [PubMed] [Google Scholar]
  15. Fiascone J. M., Rhodes T. T., Grandgeorge S. R., Knapp M. A. Bronchopulmonary dysplasia: a review for the pediatrician. Curr Probl Pediatr. 1989 Apr;19(4):169–227. doi: 10.1016/0045-9380(89)90002-9. [DOI] [PubMed] [Google Scholar]
  16. Frank L., Groseclose E. E. Preparation for birth into an O2-rich environment: the antioxidant enzymes in the developing rabbit lung. Pediatr Res. 1984 Mar;18(3):240–244. doi: 10.1203/00006450-198403000-00004. [DOI] [PubMed] [Google Scholar]
  17. Frank L., Sosenko I. R. Undernutrition as a major contributing factor in the pathogenesis of bronchopulmonary dysplasia. Am Rev Respir Dis. 1988 Sep;138(3):725–729. doi: 10.1164/ajrccm/138.3.725. [DOI] [PubMed] [Google Scholar]
  18. Gerhardt T., Hehre D., Feller R., Reifenberg L., Bancalari E. Serial determination of pulmonary function in infants with chronic lung disease. J Pediatr. 1987 Mar;110(3):448–456. doi: 10.1016/s0022-3476(87)80516-4. [DOI] [PubMed] [Google Scholar]
  19. Groothuis J. R., Gutierrez K. M., Lauer B. A. Respiratory syncytial virus infection in children with bronchopulmonary dysplasia. Pediatrics. 1988 Aug;82(2):199–203. [PubMed] [Google Scholar]
  20. Halliday H. L., McClure G., Reid M. M. Growth and development two years after artificial surfactant replacement at birth. Early Hum Dev. 1986 Jun;13(3):323–327. doi: 10.1016/0378-3782(86)90067-8. [DOI] [PubMed] [Google Scholar]
  21. Harrod J. R., L'Heureux P., Wangensteen O. D., Hunt C. E. Long-term follow-up of severe respiratory distress syndrome treated with IPPB. J Pediatr. 1974 Feb;84(2):277–285. doi: 10.1016/s0022-3476(74)80623-2. [DOI] [PubMed] [Google Scholar]
  22. Hendeles L., Weinberger M. Theophylline. A "state of the art" review. Pharmacotherapy. 1983 Jan-Feb;3(1):2–44. doi: 10.1002/j.1875-9114.1983.tb04531.x. [DOI] [PubMed] [Google Scholar]
  23. Horbar J. D., Soll R. F., Sutherland J. M., Kotagal U., Philip A. G., Kessler D. L., Little G. A., Edwards W. H., Vidyasagar D., Raju T. N. A multicenter randomized, placebo-controlled trial of surfactant therapy for respiratory distress syndrome. N Engl J Med. 1989 Apr 13;320(15):959–965. doi: 10.1056/NEJM198904133201502. [DOI] [PubMed] [Google Scholar]
  24. Kao L. C., Durand D. J., Phillips B. L., Nickerson B. G. Oral theophylline and diuretics improve pulmonary mechanics in infants with bronchopulmonary dysplasia. J Pediatr. 1987 Sep;111(3):439–444. doi: 10.1016/s0022-3476(87)80476-6. [DOI] [PubMed] [Google Scholar]
  25. Kao L. C., Warburton D., Platzker A. C., Keens T. G. Effect of isoproterenol inhalation on airway resistance in chronic bronchopulmonary dysplasia. Pediatrics. 1984 Apr;73(4):509–514. [PubMed] [Google Scholar]
  26. Katz R., McWilliams B. Bronchopulmonary dysplasia in the pediatric intensive care unit. Crit Care Clin. 1988 Oct;4(4):755–787. [PubMed] [Google Scholar]
  27. Kendig J. W., Notter R. H., Cox C., Aschner J. L., Benn S., Bernstein R. M., Hendricks-Munoz K., Maniscalco W. M., Metlay L. A., Phelps D. L. Surfactant replacement therapy at birth: final analysis of a clinical trial and comparisons with similar trials. Pediatrics. 1988 Nov;82(5):756–762. [PubMed] [Google Scholar]
  28. Kwong M. S., Egan E. A., Notter R. H., Shapiro D. L. Double-blind clinical trial of calf lung surfactant extract for the prevention of hyaline membrane disease in extremely premature infants. Pediatrics. 1985 Oct;76(4):585–592. [PubMed] [Google Scholar]
  29. Ledley F. D. Somatic gene therapy for human disease: background and prospects. Part I. J Pediatr. 1987 Jan;110(1):1–8. doi: 10.1016/s0022-3476(87)80278-0. [DOI] [PubMed] [Google Scholar]
  30. Loeber N. V., Morray J. P., Kettrick R. G., Downes J. J. Pulmonary function in chronic respiratory failure of infancy. Crit Care Med. 1980 Oct;8(10):597–601. [PubMed] [Google Scholar]
  31. Logvinoff M. M., Lemen R. J., Taussig L. M., Lamont B. A. Bronchodilators and diuretics in children with bronchopulmonary dysplasia. Pediatr Pulmonol. 1985 Jul-Aug;1(4):198–203. doi: 10.1002/ppul.1950010406. [DOI] [PubMed] [Google Scholar]
  32. Malnick G., Pickoff A. S., Ferrer P. L., Peyser J., Bancalari E., Gelband H. Normal pulmonary vascular resistance and left ventricular hypertrophy in young infants with bronchopulmonary dysplasia: an echocardiographic and pathologic study. Pediatrics. 1980 Oct;66(4):589–596. [PubMed] [Google Scholar]
  33. Markestad T., Fitzhardinge P. M. Growth and development in children recovering from bronchopulmonary dysplasia. J Pediatr. 1981 Apr;98(4):597–602. doi: 10.1016/s0022-3476(81)80774-3. [DOI] [PubMed] [Google Scholar]
  34. Merritt T. A., Cochrane C. G., Holcomb K., Bohl B., Hallman M., Strayer D., Edwards D. K., 3rd, Gluck L. Elastase and alpha 1-proteinase inhibitor activity in tracheal aspirates during respiratory distress syndrome. Role of inflammation in the pathogenesis of bronchopulmonary dysplasia. J Clin Invest. 1983 Aug;72(2):656–666. doi: 10.1172/JCI111015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Morray J. P., Fox W. W., Kettrick R. G., Downes J. J. Improvement in lung mechanics as a function of age in the infant with severe bronchopulmonary dysplasia. Pediatr Res. 1982 Apr;16(4 Pt 1):290–294. doi: 10.1203/00006450-198204000-00009. [DOI] [PubMed] [Google Scholar]
  36. Motoyama E. K., Fort M. D., Klesh K. W., Mutich R. L., Guthrie R. D. Early onset of airway reactivity in premature infants with bronchopulmonary dysplasia. Am Rev Respir Dis. 1987 Jul;136(1):50–57. doi: 10.1164/ajrccm/136.1.50. [DOI] [PubMed] [Google Scholar]
  37. Moylan F. M., Walker A. M., Kramer S. S., Todres I. D., Shannon D. C. Alveolar rupture as an independent predictor of bronchopulmonary dysplasia. Crit Care Med. 1978 Jan-Feb;6(1):10–13. doi: 10.1097/00003246-197801000-00003. [DOI] [PubMed] [Google Scholar]
  38. Nilsson R., Grossmann G., Robertson B. Pathogenesis of neonatal lung lesions induced by artificial ventilation: evidence against the role of barotrauma. Respiration. 1980;40(4):218–225. doi: 10.1159/000194280. [DOI] [PubMed] [Google Scholar]
  39. Northway W. H., Jr, Rosan R. C., Porter D. Y. Pulmonary disease following respirator therapy of hyaline-membrane disease. Bronchopulmonary dysplasia. N Engl J Med. 1967 Feb 16;276(7):357–368. doi: 10.1056/NEJM196702162760701. [DOI] [PubMed] [Google Scholar]
  40. Ogden B. E., Murphy S. A., Saunders G. C., Pathak D., Johnson J. D. Neonatal lung neutrophils and elastase/proteinase inhibitor imbalance. Am Rev Respir Dis. 1984 Nov;130(5):817–821. doi: 10.1164/arrd.1984.130.5.817. [DOI] [PubMed] [Google Scholar]
  41. PETERSON H. G., Jr, PENDLETON M. E. Contrasting roentgenographic pulmonary patterns of the hyaline membrane and fetal aspiration syndromes. Am J Roentgenol Radium Ther Nucl Med. 1955 Nov;74(5):800–817. [PubMed] [Google Scholar]
  42. Reynolds M. S., Wallander K. A. Use of surfactant in the prevention and treatment of neonatal respiratory distress syndrome. Clin Pharm. 1989 Aug;8(8):559–576. [PubMed] [Google Scholar]
  43. Robertson B. Surface forces in respiratory bronchioles during a first breath-model experiment and some theoretical considerations. Scand J Respir Dis. 1976;57(4):160–162. [PubMed] [Google Scholar]
  44. Samet J. M., Tager I. B., Speizer F. E. The relationship between respiratory illness in childhood and chronic air-flow obstruction in adulthood. Am Rev Respir Dis. 1983 Apr;127(4):508–523. doi: 10.1164/arrd.1983.127.4.508. [DOI] [PubMed] [Google Scholar]
  45. Sauve R. S., Singhal N. Long-term morbidity of infants with bronchopulmonary dysplasia. Pediatrics. 1985 Nov;76(5):725–733. [PubMed] [Google Scholar]
  46. Shoemaker C. T., Reiser K. M., Goetzman B. W., Last J. A. Elevated ratios of type I/III collagen in the lungs of chronically ventilated neonates with respiratory distress. Pediatr Res. 1984 Nov;18(11):1176–1180. doi: 10.1203/00006450-198411000-00025. [DOI] [PubMed] [Google Scholar]
  47. Smyth J. A., Tabachnik E., Duncan W. J., Reilly B. J., Levison H. Pulmonary function and bronchial hyperreactivity in long-term survivors of bronchopulmonary dysplasia. Pediatrics. 1981 Sep;68(3):336–340. [PubMed] [Google Scholar]
  48. Taghizadeh A., Reynolds E. O. Pathogenesis of bronchopulmonary dysplasia following hyaline membrane disease. Am J Pathol. 1976 Feb;82(2):241–264. [PMC free article] [PubMed] [Google Scholar]
  49. Vaucher Y. E., Merritt T. A., Hallman M., Jarvenpaa A. L., Telsey A. M., Jones B. L. Neurodevelopmental and respiratory outcome in early childhood after human surfactant treatment. Am J Dis Child. 1988 Sep;142(9):927–930. doi: 10.1001/archpedi.1988.02150090025015. [DOI] [PubMed] [Google Scholar]
  50. Vohr B. R., Bell E. F., Oh W. Infants with bronchopulmonary dysplasia. Growth pattern and neurologic and developmental outcome. Am J Dis Child. 1982 May;136(5):443–447. doi: 10.1001/archpedi.1982.03970410061015. [DOI] [PubMed] [Google Scholar]
  51. Wang E. E., Frayha H., Watts J., Hammerberg O., Chernesky M. A., Mahony J. B., Cassell G. H. Role of Ureaplasma urealyticum and other pathogens in the development of chronic lung disease of prematurity. Pediatr Infect Dis J. 1988 Aug;7(8):547–551. [PubMed] [Google Scholar]
  52. Watts J. L., Ariagno R. L., Brady J. P. Chronic pulmonary disease in neonates after artificial ventilation: distribution of ventilation and pulmonary interstitial emphysema. Pediatrics. 1977 Sep;60(3):273–281. [PubMed] [Google Scholar]
  53. Werthammer J., Brown E. R., Neff R. K., Taeusch H. W., Jr Sudden infant death syndrome in infants with bronchopulmonary dysplasia. Pediatrics. 1982 Mar;69(3):301–304. [PubMed] [Google Scholar]
  54. Wilkie R. A., Bryan M. H. Effect of bronchodilators on airway resistance in ventilator-dependent neonates with chronic lung disease. J Pediatr. 1987 Aug;111(2):278–282. doi: 10.1016/s0022-3476(87)80087-2. [DOI] [PubMed] [Google Scholar]
  55. Yeh T. F., McClenan D. A., Ajayi O. A., Pildes R. S. Metabolic rate and energy balance in infants with bronchopulmonary dysplasia. J Pediatr. 1989 Mar;114(3):448–451. doi: 10.1016/s0022-3476(89)80569-4. [DOI] [PubMed] [Google Scholar]

Articles from Archives of Disease in Childhood are provided here courtesy of BMJ Publishing Group

RESOURCES